GlassScriptPhysician profile
Preston Hassell
NPI 1548852213
$2,104.42
in general payments reported to CMS, 2019-2025
18 companies · $678 in 2025
The $678 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $257 · 2023: $587 · 2024: $470 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $603.89 | 2022-2025 | Xtampza, Belbuca, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $398.85 | 2022-2025 | Relistor |
| Forte Bio-Pharma LLC | $262.73 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Si-Bone, INC. | $145.36 | 2025 | |
| Averitas Pharma INC. | $134.17 | 2023-2025 | Qutenza |
| Scilex Pharmaceuticals INC. | $88.95 | 2022-2023 | Ztlido |
| Lilly USA, LLC | $79.66 | 2022-2023 | Reyvow, Emgality |
| Pfizer INC. | $60.00 | 2023 | |
| Appliedvr INC | $52.85 | 2025 | Relievrx |
| Valinor Pharma, LLC | $51.30 | 2025 | Movantik |
| Saluda Medical Americas, INC. | $44.62 | 2025 | Evoke |
| Grt US Holding, INC. | $42.61 | 2021-2022 | |
| Medtronic, INC. | $32.89 | 2021-2022 | |
| Sk Life Science, INC. | $26.50 | 2021 | |
| Biodelivery Sciences International, INC. | $24.80 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $20.54 | 2025 | Skyclarys |
| Amgen INC. | $19.28 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preston Hassell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.